全文获取类型
收费全文 | 2468067篇 |
免费 | 207877篇 |
国内免费 | 11810篇 |
专业分类
耳鼻咽喉 | 35183篇 |
儿科学 | 73889篇 |
妇产科学 | 64965篇 |
基础医学 | 344923篇 |
口腔科学 | 69353篇 |
临床医学 | 228869篇 |
内科学 | 481132篇 |
皮肤病学 | 49045篇 |
神经病学 | 205140篇 |
特种医学 | 99744篇 |
外国民族医学 | 956篇 |
外科学 | 370668篇 |
综合类 | 74306篇 |
现状与发展 | 25篇 |
一般理论 | 982篇 |
预防医学 | 196090篇 |
眼科学 | 58722篇 |
药学 | 188633篇 |
115篇 | |
中国医学 | 10185篇 |
肿瘤学 | 134829篇 |
出版年
2019年 | 21073篇 |
2018年 | 28065篇 |
2017年 | 22232篇 |
2016年 | 23808篇 |
2015年 | 28212篇 |
2014年 | 39666篇 |
2013年 | 56504篇 |
2012年 | 77028篇 |
2011年 | 81459篇 |
2010年 | 48082篇 |
2009年 | 45268篇 |
2008年 | 74723篇 |
2007年 | 79062篇 |
2006年 | 80032篇 |
2005年 | 78089篇 |
2004年 | 73372篇 |
2003年 | 70747篇 |
2002年 | 69382篇 |
2001年 | 114596篇 |
2000年 | 118691篇 |
1999年 | 100453篇 |
1998年 | 28115篇 |
1997年 | 25738篇 |
1996年 | 25178篇 |
1995年 | 25829篇 |
1994年 | 24205篇 |
1993年 | 22194篇 |
1992年 | 80188篇 |
1991年 | 77196篇 |
1990年 | 74232篇 |
1989年 | 71376篇 |
1988年 | 66303篇 |
1987年 | 65218篇 |
1986年 | 61635篇 |
1985年 | 58677篇 |
1984年 | 44309篇 |
1983年 | 37662篇 |
1982年 | 22871篇 |
1981年 | 20311篇 |
1979年 | 41298篇 |
1978年 | 28948篇 |
1977年 | 24268篇 |
1976年 | 22784篇 |
1975年 | 23934篇 |
1974年 | 29617篇 |
1973年 | 28031篇 |
1972年 | 26218篇 |
1971年 | 24156篇 |
1970年 | 22731篇 |
1969年 | 21073篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
103.
目的探讨肾周脂肪梅奥粘连概率评分系统(MAP)在肾癌后腹腔镜肾部分切除术中的临床应用价值。 方法回顾性分析2015年1月至2020年6月徐州医科大学附属淮安医院泌尿外科收治的行后腹腔镜肾部分切除术的153例肾癌患者的临床病例资料。依据MAP评分系统将其分为低度复杂组、中度复杂组和高度复杂组三组。比较各组间的手术时间、术中出血量、术中及术后并发症、术中热缺血时间、术后住院时间及术后血肌酐变化情况。 结果在153例患者中,低度复杂组68例,中度复杂组58例和高度复杂组27例。三组患者在年龄、性别、术前血肌酐水平、肿瘤最大径、肿瘤位置、BMI、RENAL评分等方面差异无统计学意义(P>0.05)。随着复杂程度的提高,手术时间、术中出血量也在不断增加(P<0.05);而术中热缺血时间、术后住院时间及术后血肌酐水平无明显变化(P>0.05)。在术中并发症方面,随着复杂程度的提高,术中并发症的发生率也在增加(P<0.05),且高度复杂组的术后并发症发生风险是低度复杂组的13.895倍(P=0.002),MAP评分系统预测术中并发症发生的精度较高(AUC=0.757,P=0.002)。但是术后并发症各组比较差异无统计学意义(P>0.05)。 结论MAP评分系统在肾癌后腹腔镜肾部分切除术中,对预估手术难度及术中并发症发生风险有较好的临床应用价值。 相似文献
104.
K. El-Boghdadly T. M. Cook T. Goodacre J. Kua S. Denmark S. McNally N. Mercer S. R. Moonesinghe D. J. Summerton 《Anaesthesia》2022,77(5):580-587
The impact of vaccination and new SARS-CoV-2 variants on peri-operative outcomes is unclear. We aimed to update previously published consensus recommendations on timing of elective surgery after SARS-CoV-2 infection to assist policymakers, administrative staff, clinicians and patients. The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting. We recommend individualised multidisciplinary risk assessment for patients requiring elective surgery within 7 weeks of SARS-CoV-2 infection. This should include baseline mortality risk calculation and assessment of risk modifiers (patient factors; SARS-CoV-2 infection; surgical factors). Asymptomatic SARS-CoV-2 infection with previous variants increased peri-operative mortality risk three-fold throughout the 6 weeks after infection, and assumptions that asymptomatic or mildly symptomatic omicron SARS-CoV-2 infection does not add risk are currently unfounded. Patients with persistent symptoms and those with moderate-to-severe COVID-19 may require a longer delay than 7 weeks. Elective surgery should not take place within 10 days of diagnosis of SARS-CoV-2 infection, predominantly because the patient may be infectious, which is a risk to surgical pathways, staff and other patients. We now emphasise that timing of surgery should include the assessment of baseline and increased risk, optimising vaccination and functional status, and shared decision-making. While these recommendations focus on the omicron variant and current evidence, the principles may also be of relevance to future variants. As further data emerge, these recommendations may be revised. 相似文献
105.
A.
Cumberworth H. Lewith A. Sud H. Jefferson V. Athanassoglou J. J. Pandit 《Anaesthesia》2022,77(6):640-648
We conducted an observational study of serious airway complications, using similar methods to the fourth UK National Audit Project (NAP4) over a period of 1 year across four hospitals in one region in the UK. We also conducted an activity survey over a week, using NAP4 methods to yield an estimate for relevant denominators to help interpret the primary data. There were 17 serious airway complications, defined as: failed airway management leading to cancellation of surgery (eight); airway management in recovery (five); unplanned intensive care admission (three); and unplanned emergency front of neck access (one). There were no reports of death or brain damage. This was an estimate of 0.028% (1 in 3600) complications using the denominator of 61,000 general anaesthetics per year in the region. Complications in patients with ‘predicted easy’ airways were rare (approximately 1 in 14,200), but 45 times more common in those with ‘predicted difficult’ airways (approximately 1 in 315). Airway management in both groups was similar (induction of anaesthesia followed by supraglottic airway or tracheal tube). Use of awake/sedation intubation, videolaryngoscopy and high-flow nasal oxygenation were uncommon even in the predicted difficult airway patients (in 2.7%, 32.4% and 9.5% of patients, respectively). We conclude that the incidence of serious airway complications is at least as high as it was during NAP4. Despite airway prediction being used, this is not informing subsequent management. 相似文献
106.
107.
108.
Alexander D. Sherry MD Kelsey L. Corrigan MD MPH Ramez Kouzy MD Joseph Abi Jaoude MD Yumeng Yang MS Roshal R. Patel MD Douglas J. Totten MD MBA Neil B. Newman MD MS Prajnan Das MD MS MPH Cullen Taniguchi MD PhD Bruce Minsky MD Rebecca A. Snyder MD MPH C. David Fuller MD PhD Ethan Ludmir MD 《Cancer》2023,129(21):3430-3438
109.